AI assistant
Phathom Pharmaceuticals, Inc. — Director's Dealing 2025
Oct 8, 2025
32407_dirs_2025-10-08_c1cdcc12-18dc-48e6-8eeb-dac7d0744ee5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2025-10-06
Reporting Person: Narula Sanjeev (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-06 | Common Stock | A | 144000 | — | Acquired | 144000 | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") granted on October 6, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of October 6, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2: This amendment is being filed to report the transaction which was inadvertently omitted in the Form 4 filed on behalf of the Reporting Person on October 7, 2025.